How a system of high-tech cameras provide the Knicks with analytics they’ve never had before
The Knicks are taking advantage of the latest development in player tracking in each NBA arena.
Articles for tag
analytics
-
-
Black Friday spending hits online record as shoppers avoid crowds
Buyers spent a record $9.8B online Friday, according to Adobe Analytics. Electronics like smartwatches, televisions, and Bluetooth headphones were hot ticket items. -
Buy now, save later debt skyrockets during Cyber Monday sales
A record amount of price-pinched holiday shoppers are expected to use buy now, pay later services for Cyber Monday to relieve stress on their wallets, according to Adobe Analytics. -
New Yankees coach Brad Ausmus doesn’t see analytics as ‘entire answer to winning’
Brad Ausmus joins an organization that had trouble winning baseball games last season, which has placed increased scrutiny on how the Yankees operate. -
Yankees’ stat guru Michael Fishman defends analytics, but indicates changes planned
A month after Brian Cashman vehemently defended the Yankees’ analytics department, the man who runs it insisted their model had not gotten stale. -
The FDA has reportedly approved an AI product that predicts cognitive decline
The US government has reportedly approved AI-based memory loss prediction software for the first time. Darmiyan, a San Francisco-based brain imaging analytics company, says the FDA has granted De Novo approval for its product BrainSee. The software... -
The FDA has reportedly approved an AI product that predicts cognitive decline
The US government has reportedly approved AI-based memory loss prediction software for the first time. Darmiyan, a San Francisco-based brain imaging analytics company, says the FDA has granted De Novo approval for its product BrainSee. The software... -
The FDA has reportedly approved an AI product that predicts cognitive decline
The US government has reportedly approved AI-based memory loss prediction software for the first time. Darmiyan, a San Francisco-based brain imaging analytics company, says the FDA has granted De Novo approval for its product BrainSee. The software... -
The FDA has reportedly approved an AI product that predicts cognitive decline
The US government has reportedly approved AI-based memory loss prediction software for the first time. Darmiyan, a San Francisco-based brain imaging analytics company, says the FDA has granted De Novo approval for its product BrainSee. The software... -
The FDA has reportedly approved an AI product that predicts cognitive decline
The US government has reportedly approved AI-based memory loss prediction software for the first time. Darmiyan, a San Francisco-based brain imaging analytics company, says the FDA has granted De Novo approval for its product BrainSee. The software... -
The FDA has reportedly approved an AI product that predicts cognitive decline
The US government has reportedly approved AI-based memory loss prediction software for the first time. Darmiyan, a San Francisco-based brain imaging analytics company, says the FDA has granted De Novo approval for its product BrainSee. The software... -
The FDA has reportedly approved an AI product that predicts cognitive decline
The US government has reportedly approved AI-based memory loss prediction software for the first time. Darmiyan, a San Francisco-based brain imaging analytics company, says the FDA has granted De Novo approval for its product BrainSee. The software... -
The FDA has reportedly approved an AI product that predicts cognitive decline
The US government has reportedly approved AI-based memory loss prediction software for the first time. Darmiyan, a San Francisco-based brain imaging analytics company, says the FDA has granted De Novo approval for its product BrainSee. The software... -
The FDA has reportedly approved an AI product that predicts cognitive decline
The US government has reportedly approved AI-based memory loss prediction software for the first time. Darmiyan, a San Francisco-based brain imaging analytics company, says the FDA has granted De Novo approval for its product BrainSee. The software... -
The FDA has reportedly approved an AI product that predicts cognitive decline
The US government has reportedly approved AI-based memory loss prediction software for the first time. Darmiyan, a San Francisco-based brain imaging analytics company, says the FDA has granted De Novo approval for its product BrainSee. The software... -
The FDA has reportedly approved an AI product that predicts cognitive decline
The US government has reportedly approved AI-based memory loss prediction software for the first time. Darmiyan, a San Francisco-based brain imaging analytics company, says the FDA has granted De Novo approval for its product BrainSee. The software... -
The FDA has reportedly approved an AI product that predicts cognitive decline
The US government has reportedly approved AI-based memory loss prediction software for the first time. Darmiyan, a San Francisco-based brain imaging analytics company, says the FDA has granted De Novo approval for its product BrainSee. The software... -
The FDA has reportedly approved an AI product that predicts cognitive decline
The US government has reportedly approved AI-based memory loss prediction software for the first time. Darmiyan, a San Francisco-based brain imaging analytics company, says the FDA has granted De Novo approval for its product BrainSee. The software... -
The FDA has reportedly approved an AI product that predicts cognitive decline
The US government has reportedly approved AI-based memory loss prediction software for the first time. Darmiyan, a San Francisco-based brain imaging analytics company, says the FDA has granted De Novo approval for its product BrainSee. The software... -
The FDA has reportedly approved an AI product that predicts cognitive decline
The US government has reportedly approved AI-based memory loss prediction software for the first time. Darmiyan, a San Francisco-based brain imaging analytics company, says the FDA has granted De Novo approval for its product BrainSee. The software...
